Although DPP‐4is have their place in the treatment of T2D, their potential as a weight loss drug or their overall efficacy should be considered limited when compared to the numerous beneficial effects of GLP‐1 RAs and potential future combinations. Here, GLP1R is linked to type 2 diabetes mellitus.